At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 12, 2026 at 10:34 ET
GSK filed a Form 6-K reporting routine share acquisitions by multiple PDMRs (directors and senior executives) under the company's Share Reward Plan on November 10, 2026. The transactions are small in value and represent standard equity plan participation, not open-market purchases. No financial results or material corporate events are disclosed.
- Eight PDMRs and one PCA acquired ordinary shares under GSK's Share Reward Plan on November 10, 2026
- Each PDMR (except Victoria Whyte) acquired 12 ordinary shares at GBP 19.3453 per share; Victoria Whyte acquired 14 shares
- Maya Martinez-Davis acquired 9.264 notional ADS at $51.5400 in her Executive Supplemental Savings Plan account on November 9, 2026
- Total value of all ordinary share acquisitions is approximately GBP 2,088 (about $2,600)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access